Methods This was a randomized, double-blind, placebo-controlled trial
Preliminary studies suggest that retatrutide not only aids in weight loss but also enhances insulin sensitivity, making it a dual-action agent in the fight against obesity-related health issues
It works by gradually supporting your bodys internal stores and helping maintain a balanced cellular environment over time
Juan Pablo Frias, MD, medical director and principal investigator of the National Research Institute (NRI), said: "The FDA's decision to approve the additional dose of Trulicity is a positive development for patients with type 2 diabetes and their caregivers
Rekhi B, Ingle A, Kumar R, et al
CBER 24-671405] (Formerly titled: Konrad Rejdak, M.D., Ph.D.) FDA Warning Letter to Academic IRB (June 21, 2024) Failure to include required consent elements, recurring documentation issues, and inadequate IRB membership records